(19)
(11) EP 4 192 495 A1

(12)

(43) Date of publication:
14.06.2023 Bulletin 2023/24

(21) Application number: 21773170.2

(22) Date of filing: 06.08.2021
(51) International Patent Classification (IPC): 
A61K 38/18(2006.01)
A61K 31/53(2006.01)
A61P 1/16(2006.01)
A61K 31/4178(2006.01)
A61K 47/60(2017.01)
(52) Cooperative Patent Classification (CPC):
A61K 38/1825; A61K 47/60; A61K 31/53; A61P 1/16; A61K 31/517
 
C-Sets:
  1. A61K 31/53, A61K 2300/00;
  2. A61K 31/517, A61K 2300/00;

(86) International application number:
PCT/US2021/045090
(87) International publication number:
WO 2022/032187 (10.02.2022 Gazette 2022/06)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 07.08.2020 US 202063063189 P
13.08.2020 US 202063065414 P
14.08.2020 US 202063065749 P
14.08.2020 US 202063065935 P
18.08.2020 US 202063067184 P

(71) Applicants:
  • Bristol-Myers Squibb Company
    Princeton, NJ 08543 (US)
  • Universitaetsmedizin Berlin
    10117 Berlin (DE)
  • Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen
    52056 Aachen (DE)
  • Universiteit Gent
    9052 Gent (BE)
  • Tacke, Frank
    10117 Berlin (DE)
  • Puengel, Tobias
    10117 Berlin (DE)
  • Lefere, Sander
    9052 Gent-Zwijnaarde (BE)

(72) Inventors:
  • BOEHM, Stephanie Lauren
    Philadelphia, Pennsylvania 19047 (US)
  • ZHAO, Qihong
    Princeton, New Jersey 08540 (US)
  • CHARLES, Edgar Davidson, III
    Westfield, New Jersey 07090 (US)
  • ZINKER, Bradley A.
    Newtown, Pennsylvania 18940 (US)
  • TACKE, Frank
    10117 Berlin (DE)
  • PUENGEL, Tobias
    10117 Berlin (DE)
  • LEFERE, Sander
    9052 Gent-Zwijnaarde (BE)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) FGF21 COMBINED WITH CCR2/5 ANTAGONISTS FOR THE TREATMENT OF FIBROSIS